Coumarin-Ser-Asp-Lys-Pro-OH, a fluorescent substrate for determination of angiotensin-converting enzyme activity via high-performance liquid chromatography.
暂无分享,去创建一个
[1] P. Deddish,et al. Single-domain angiotensin I converting enzyme (kininase II): characterization and properties. , 1996, The Journal of pharmacology and experimental therapeutics.
[2] J. Ménard,et al. Acute angiotensin-converting enzyme inhibition increases the plasma level of the natural stem cell regulator N-acetyl-seryl-aspartyl-lysyl-proline. , 1996, The Journal of clinical investigation.
[3] P. Corvol,et al. The Hemoregulatory Peptide N-Acetyl-Ser-Asp-Lys-Pro Is a Natural and Specific Substrate of the N-terminal Active Site of Human Angiotensin-converting Enzyme (*) , 1995, The Journal of Biological Chemistry.
[4] H. Gavras,et al. Corcoran Lecture. Angiotensin-converting enzyme inhibition and the heart. , 1994, Hypertension.
[5] J. Wdzieczak‐Bakala,et al. Involvement of human plasma angiotensin I-converting enzyme in the degradation of the haemoregulatory peptide N-acetyl-seryl-aspartyl-lysyl-proline. , 1993, The Biochemical journal.
[6] Lei Wei,et al. Differences in the properties and enzymatic specificities of the two active sites of angiotensin I-converting enzyme (kininase II). Studies with bradykinin and other natural peptides. , 1993, The Journal of biological chemistry.
[7] Lei Wei,et al. The two homologous domains of human angiotensin I-converting enzyme are both catalytically active. , 1991, The Journal of biological chemistry.
[8] M. Lenfant,et al. Radiosynthesis of highly labelled [3H]Ac-Ser-Asp-Lys-Pro: A natural regulator of hematopoietic system , 1991 .
[9] B. Bénéteau-Burnat,et al. Angiotensin-converting enzyme: clinical applications and laboratory investigations on serum and other biological fluids. , 1991, Critical reviews in clinical laboratory sciences.
[10] M. Lenfant,et al. Synthesis and activity of NAcSerAspLysPro analogues on cellular interactions between T-cell and erythrocytes in rosette formation. , 1990, Journal of medicinal chemistry.
[11] E. Guittet,et al. Inhibitor of hematopoietic pluripotent stem cell proliferation: purification and determination of its structure. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[12] P Corvol,et al. Two putative active centers in human angiotensin I-converting enzyme revealed by molecular cloning. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[13] B. Vallee,et al. Metal-coordinating substrate analogs as inhibitors of metalloenzymes. , 1979, Proceedings of the National Academy of Sciences of the United States of America.
[14] D W Cushman,et al. Spectrophotometric assay and properties of the angiotensin-converting enzyme of rabbit lung. , 1971, Biochemical pharmacology.
[15] E. G. Erdös,et al. A dipeptidyl carboxypeptidase that converts angiotensin I and inactivates bradykinin. , 1970, Biochimica et biophysica acta.
[16] L. Skeggs,et al. THE PREPARATION AND FUNCTION OF THE HYPERTENSIN-CONVERTING ENZYME , 1956, The Journal of experimental medicine.